{"id":"W2792297805","doi":"10.1158/1538-7445.sabcs17-gs1-02","title":"Abstract GS1-02: NSABP B-47 (NRG oncology): Phase III randomized trial comparing adjuvant chemotherapy with adriamycin (A) and cyclophosphamide (C) → weekly paclitaxel (WP), or docetaxel (T) and C with or without a year of trastuzumab (H) in women with node-positive or high-risk node-negative invasive breast cancer (IBC) expressing HER2 staining intensity of IHC 1+ or 2+ with negative FISH (HER2-Low IBC)","year":2018,"lang":"en","type":"article","venue":"Cancer Research","topic":"Breast Cancer Treatment Studies","field":"Biochemistry, Genetics and Molecular Biology","cited_by":50,"is_retracted":false,"has_abstract":true,"ca_institutions":"Université du Québec à Montréal","funders":"","keywords":"Medicine; Docetaxel; Cyclophosphamide; Internal medicine; Paclitaxel; Trastuzumab; Breast cancer; Chemotherapy; Oncology; Cohort; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002099373,0.001961865,0.001700391,0.0005664077,0.0002905969,0.001015834,0.0009595526,0.001476248,0.008819692],"category_scores_gemma":[0.001417367,0.00068125,0.001353519,0.000574511,0.001513362,0.0007407753,0.0004890062,0.002770626,0.001574784],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0013812,"about_ca_system_score_gemma":0.002254273,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002252803,"about_ca_topic_score_gemma":0.005488908,"domain_scores_codex":[0.9993587,0.0004056245,0.00002892869,0.00008318645,0.0000393435,0.00008423214],"domain_scores_gemma":[0.9993201,0.0001353068,0.0001441221,0.00004670782,0.00003168582,0.0003220351],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.977992,0.006754701,0.0008882211,0.0003127124,0.0004931972,0.00002796649,0.00003768064,0.0004854418,0.002861953,0.0001270181,0.001088119,0.008931065],"study_design_scores_gemma":[0.9368347,0.05978845,0.001534244,0.00002099296,0.0003200756,0.0000231791,0.0000174396,0.0002873036,0.0003906171,0.0001223441,0.000651277,0.000009338075],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9843481,0.001678591,0.0003872505,0.001149617,0.0003429165,0.006397197,0.002752382,0.0001810073,0.002763095],"genre_scores_gemma":[0.9800135,0.001676524,0.001290178,0.001751045,0.0003395779,0.005785954,0.003040756,0.00003280202,0.006069644],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.008819692,"threshold_uncertainty_score":0.02950484,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02801587497886952,"score_gpt":0.3486141053068592,"score_spread":0.3205982303279897,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}